#IONS

Last 24h 📉 Bearish 📉1

Last 7 Days 📉 Bearish 📉1 📊1

Last 30 Days 📉 Bearish 📉1 📊1

📈 Stocks — 📉 Bearish

Novartis Shares Plunge 12% Following Dual Phase 3 Clinical Trial Failures

September 9, 2026 (36 minutes ago)

Novartis shares fell 12.57% following two major clinical trial disappointments, triggering a broader sell-off in biotech partners Ionis Pharmaceuticals and Royalty Pharma.

🌍 NORTH AMER Read More →

📈 Stocks

Ionis Pharmaceuticals Shares Slide 13% Following Failed Phase 3 Drug Trial

September 8, 2026 (1 day ago)

Ionis Pharmaceuticals stock hit near 52-week lows after the Phase 3 trial for its cardiovascular drug pelacarsen failed to meet primary endpoints,…

^GSPC DJI NDX

🌍 NORTH AMER Read More →